Skip to main content
Membership NewsMembership News Archive

Helen interviewed by Genowrite ahead of London Biotechnology Show

BIVDA Interim Chief Executive, Helen Dent, was interviewed for Genowrite by Paul Naphtali. Helen spoke about the important role of IVDs and how BIVDA works to develop a thriving UK market for members. To achieve this, Helen touched upon the four key areas of focus which drives BIVDA activities, including influencing key stakeholders and encouraging the appropriate use and increased…
Dawn
March 13, 2024